Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Rhonda Schreiber
Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis
Main Article Content Adelaide Herbert UT Health McGovern Medical School, Houston, TX, USA Rhonda Schreiber Mayne Pharma Debbie Glaab Mayne Pharma Lawrence Eichenfeld UC San Diego Keywords halobetasol foam, adrenal suppresion, psoriasis Abstract N/A References 1. Bronker et al. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Pediatr Drugs (2015) 17:373–384. DOI 10.1007/s40272-015-0137-1. 2. Paller et al.
Review of Mechanisms of Release of Commonly Prescribed Tetracyclines
Main Article Content Pearl Kwong Hilary Baldwin Debbie Glaab Rhonda Schreiber Emma Hignett Keywords Pharmacology, Tetracycline, Mechanism of Release Abstract Abstract not available. References 1. Barbieri JS, Bhate K, Hartnett KP, Fleming Dutra KE, Margolis DJ Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016 JAMA Dermatol 2019 155 3 290 297 doi 10 1001 /jamadermatol 2018 4944 2.
Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris
Main Article Content James Q Del Rosso Corey L Hartman Caitlin Lewis Rhonda Schreiber Keywords Acne Vulgaris, Acne, Tazarotene, retinoid Abstract Abstract not available. Abstract 1 | Poster PDF Downloads 0 References 1.
A Multicenter, Open Label, Phase 1 Study of the Safety, Tolerability, Systemic Exposure, Pharmacodynamics, and Treatment Effect of Calcipotriene Foam, 0.005% in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis | SKIN The Journal of Cutaneous
Main Article Content Adelaide A Herbert Debbie Glaab Rhonda Schreiber Keywords Psoriasis, Calcipotriene, Corticosteroid, Halobetasol Abstract Abstract not available. Abstract 3 | Poster PDF Downloads 0 References 1. National Psoriasis Foundation 2019 July 31 About Psoriasis Retrieved from Psoriasis Org www psoriasis org/parents/about psoriasis 2.
Combination of Calcipotriene 0.005% Foam and Halobetasol Propionate 0.05% Foam in the Treatment of Scalp Psoriasis
Main Article Content Alexis Young Rhonda Schreiber Keywords Psoriasis, Calcipotriene, Corticosteroid, Halobetasol Abstract Abstract not available. Abstract 2 | Poster PDF Downloads 0 References 1. National Psoriasis Foundation. (2019, July 31). About Psoriasis. Retrieved from Psoriasis.Org : www.psoriasis.org/parents/about psoriasis. 2. American Academy of Dermatology. (n.d.). Psoriasis clinical guideline.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rhonda
Contact Rhonda, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack